<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04676191</url>
  </required_header>
  <id_info>
    <org_study_id>U1111-1248-9457</org_study_id>
    <nct_id>NCT04676191</nct_id>
  </id_info>
  <brief_title>Validation of a Contactless Vital Signs Measurement Sensor</brief_title>
  <official_title>Single- Center Performance Assessment of a Contactless Sensor for Vital Physiological Parameters Measurement at Rest and Detection of Diagnostic Indices in Sleep Compared to Cardiorespiratory Polygraphy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sleepiz AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sleepiz AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to validate the performance of Sleepiz One+ for the&#xD;
      measurement of vital physiological parameters in adult population, against a laboratory-based&#xD;
      polysomnography. Additionally, the investigators will evaluate Sleepiz One+ ability to&#xD;
      identify patients with a high risk of suffering from a sleep-related breathing disorder based&#xD;
      on apnea-hypopnea index estimation. Participants will undergo measurement with Sleepiz One+&#xD;
      and a polysomnography device while resting in bed for 20 min as well as during sleep for the&#xD;
      duration of the following night.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 10, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiration rate measurement accuracy agreement</measure>
    <time_frame>60 seconds</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Binary classification of sleep apnea severity based on the AHI &gt; 15 of Sleepiz One+ compared to results of Domino software and data manually scored by sleep technician</measure>
    <time_frame>1 Night</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Instantaneous respiration rate agreement between Sleepiz One+ and nasal cannula</measure>
    <time_frame>60 seconds</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average respiration rate agreement between Sleepiz One+ and thoracic respiratory effort belt</measure>
    <time_frame>1 Night</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average respiration rate agreement between Sleepiz One+ and nasal cannula</measure>
    <time_frame>1 Night</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep/wake classification agreement between Sleepiz One+ compared to polysomnography (PSG) data manually scored by sleep technician</measure>
    <time_frame>60 seconds</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Patients with sleep disorders, cardiorespiratory or neuromuscular disorders</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sleepiz One+</intervention_name>
    <description>Simultaneous sleep study with polysomnography and Sleepiz One+</description>
    <arm_group_label>Patients with sleep disorders, cardiorespiratory or neuromuscular disorders</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Polysomnography</intervention_name>
    <description>Simultaneous sleep study with polysomnography and Sleepiz One+</description>
    <arm_group_label>Patients with sleep disorders, cardiorespiratory or neuromuscular disorders</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;18years&#xD;
&#xD;
          -  Ability and consent to undergo electrophysiological routine assessment&#xD;
&#xD;
          -  Informed Consent as documented by signature&#xD;
&#xD;
          -  Patients diagnosed or suspected to suffer from sleep apnea or any other sleep related&#xD;
             disorder or patients suffering from chronic cardiac, respiratory or neuromuscular&#xD;
             disorders&#xD;
&#xD;
          -  Ambulatory or stationary patients of Klinik Lengg&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous enrolment into the current study,&#xD;
&#xD;
          -  Enrolment of the investigator, his/her family members, employees and other dependent&#xD;
             persons&#xD;
&#xD;
          -  Cardiac pacemaker or another implanted electrical device&#xD;
&#xD;
          -  Women who are pregnant&#xD;
&#xD;
          -  Inability to follow the procedures of the study, e.g. due to language problems,&#xD;
             psychological disorders, dementia, delirium etc. of the participant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bartosz Bujan, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik Lengg AG</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marta Stepien</last_name>
    <phone>767837350</phone>
    <email>marta.stepien@sleepiz.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Klinik Lengg AG</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bartosz Bujan, Dr. med.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 9, 2020</study_first_submitted>
  <study_first_submitted_qc>December 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2020</study_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>respiration</keyword>
  <keyword>sleep</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

